SciFluor Life Sciences

SciFluor Life Sciences is a drug discovery company developing a broad portfolio of differentiated best-in-class therapeutics to treat various diseases.
The company creates patentable new chemical entities (NCEs) directed towards precedented biological targets. SciFluor strategically incorporates fluorine or fluorine-containing groups to design drugs with improved pharmacological profiles that provide important benefits over existing therapies such as improved safety, efficacy, dosing, and patient compliance. This capital-efficient and de-risked drug discovery approach has resulted in the generation of a proprietary pipeline of novel and differentiated small molecule drugs across a diverse range of therapeutic categories and disease areas including retinal disease, CNS disorders, pain, and respiratory and inflammatory diseases. We are advancing selected development candidates into clinical studies and actively seeking industry partners to drive the development and commercialization of our innovative new medicines.